NCT07205666View on ClinicalTrials.gov

The Eplontersen Pregnancy and Lactation Outcomes Study

Not yet recruitingOBSERVATIONAL

Enrollment

10

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

December 30, 2035

Study Completion Date

December 30, 2035

Conditions

Transthyretin Amyloidosis

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

ICON plc

INDUSTRY

lead

AstraZeneca

INDUSTRY